The effects of methylphenidate on the classroom behavior of elementary school-age children with cerebral palsy: A preliminary observational analysis

Journal of Child Neurology

Volumn 22, Issue 1, 2007, Pages 89-94

  Symons, Frank J ^a   Tervo, Raymond C ^b,c   Kim, Ockjean ^d   Hoch, John ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c Pediatric Section   (United States)

^d MINNESOTA STATE UNIVERSITY   (United States)

Author keywords

ADHD; Cerebral palsy; Methylphenidate

Indexed keywords

METHYLPHENIDATE; PLACEBO;

ABSENCE OF SIDE EFFECTS; ARTICLE; ATTENTION DEFICIT DISORDER; CASE REPORT; CEREBRAL PALSY; CHILD BEHAVIOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISRUPTIVE BEHAVIOR; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG MEGADOSE; FEMALE; HUMAN; LOW DRUG DOSE; MALE; MEDICAL RESEARCH; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIMARY SCHOOL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; STEREOTYPY; TREATMENT OUTCOME;

ATTENTION DEFICIT AND DISRUPTIVE BEHAVIOR DISORDERS; CENTRAL NERVOUS SYSTEM STIMULANTS; CEREBRAL PALSY; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; METHYLPHENIDATE; OBSERVATION; SCHOOLS; SOCIAL BEHAVIOR; STEREOTYPED BEHAVIOR;

EID: 34249858859     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/0883073807299965     Document Type: Article

References (25)

1. Dormans JP, Pellegrino L. Caring for Children With Cerebral Palsy: A Team Approach. Baltimore, Md: Paul H Brookes; 1998.
2. Harris J. Cerebral palsy. In: Howlin P, ed. Behavior Approaches to Problems in Childhood. London, UK: MacKeith Press; 1998: 136-151.
3. Eicher PS, Batshaw ML Cerebral palsy. Pediatr Clin North Am. 1993; 40: 537-551.
4. Palmer FB, Hoon AH Cerebral palsy. In: Parker S, Zuckerman B, eds. Behavioral and Developmental Pediatrics: A Handbook for Primary Care. Boston, Mass: Little, Brown; 1995: 88-94.
5. Breslau N. Psychiatric disorder in children with physical disabilities. J Am Acad Child Psychol. 1985; 24: 87-94.
6. Adesman AR, Morgan AM Management of stimulant medications in children with attention-deficit/hyperactivity disorder. Pediatr Clin North Am.1999; 46: 945-963.
7. Handen BL, Breaux AM, Gosling A., et al. Efficacy of methylphenidate among mentally retarded children with attention deficit hyperactivity disorders. Pediatrics. 1990; 86: 922-930.
8. MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 1999; 56: 1073-1086.
9. Sabbadini M., Bonanni R., Carlesimo GA, Caltagirone C. Neuropsychological assessment of patients with severe neuromotor and verbal disabilities. J Intellect Disabil. 2001; 45: 169-179.
10. Mayes SD, Crites DL, Bixler EO, et al. Methylphenidate and ADHD: influence of age, IQ and neurodevelopmental status. Develop Med Child Neurol. 1994; 36: 1099-1107.
11. Tervo RC, Estrem TL, Bryson-Brockmann W., Symons FJ Single-case experimental designs: Applications in developmental-behavioral pediatrics. J Dev Behav Pediatr. 2003; 24: 1-11.
12. Tervo R. Part II: Decisions in the management of a child with developmental disability and hyperactive-impulsive behavior using "n of 1" trials in the clinical setting. Child Adolesc Psychopharm News. 2000; 5: 6-7.
13. Varley CK, Trupin EW Double-blind administration of methylphenidate to mentally retarded children with attention deficit disorder: A preliminary study. Am J Ment Defic. 1982; 86: 560-566.
14. Handen BL, Janosky J., McAuliffe S. Long-term follow-up of children with mental retardation/borderline intellectual functioning and ADHD. J Abnorm Child Psychol. 1997; 25: 287-295.
15. Handen BL, Feldman HM, Lurier A., Murray PJ Efficacy of methylphenidate among preschool children with developmental disabilities and ADHD. J Am Acad Child Adolesc Psychiatry. 1999; 38: 805-812.
16. Johnson CR, Handen BL, Lubetsky MJ, Sacco KA Efficacy of methylphenidate and behavioral intervention on classroom behavior in children with ADHD and mental retardation. Behav Modif. 1994; 18: 470-487.
17. Gross-Tsur V., Shalev RS, Badihi N., Manor O. Efficacy of methylphenidate in patients with cerebral palsy and attention-deficit hyperactivity disorder (ADHD). J Child Neurol. 2002; 17: 863-866.
18. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Press; 1994.
19. Barkley R., Fischer M., Newby RF, et al. Development of a multimethod clinical protocol for the assessing stimulant drug response in children with attention deficit disorder. J Clin Child Psychol. 1988; 17: 14-24.
20. Blum NJ, Mauk JE, McComas JJ, Mace FC Separate and combined effects of methylphenidate and a behavioral intervention on disruptive behavior in children with mental retardation. J Appl Behav Anal. 1996; 29: 305-319.
21. Boogerd W., Beijnen JH Methylphenidate for cerebral palsy with choreoathetosis. Ann Intern Med. 2000; 132: 510.
22. Symons FJ, Thompson A., Rodriguez MC Self-injurious behavior and the efficacy of naltrexone treatment: A quantitative synthesis. Ment Retard Dev Disabil Res Rev. 2004; 10: 193-200.
23. Breese GR, Criswell HE, Duncan GE, et al. Model for reduced brain dopamine in Lesch-Nyhan syndrome and the mentally retarded: Neurobiology of neonatal-6-hydroxydopamine lesioned rats. Ment Retard Dev Disabil Res Rev. 1995; 1: 111-119.
24. Lewis MH, Bodfish JW, Powell SB, Golden RN Clomipramine treatment for stereotypy and related repetitive movement disorders in mental retardation: A double-blind comparison with placebo. Am J Ment Retard. 1996; 100: 299-312.
25. Bodfish JW, Powell SB, Golden RN, Lewis MH Blink rate as an index of dopamine function in adults with mental retardation and repetitive behavior disorders. Am J Ment Retard. 1995; 99: 335-344.